Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 1
1995 1
1997 1
1998 2
1999 1
2000 3
2002 1
2003 2
2004 2
2005 2
2006 4
2007 4
2008 5
2011 4
2012 2
2013 3
2014 3
2015 2
2017 1
2018 2
2020 2
2021 1
2022 8
2023 4
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

59 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for yishen he
Your search for Yeshen He retrieved no results
Yishen Huashi granule modulated lipid metabolism in diabetic nephropathy via PI3K/AKT/mTOR signaling pathways.
Zhao T, Xiang Q, Lie B, Chen D, Li M, Zhang X, Yang J, He B, Zhang W, Dong R, Liu Y, Gu J, Zhu Q, Yao Y, Duan T, Li Z, Xu Y. Zhao T, et al. Heliyon. 2023 Mar 2;9(3):e14171. doi: 10.1016/j.heliyon.2023.e14171. eCollection 2023 Mar. Heliyon. 2023. PMID: 36938470 Free PMC article.
Although etiology for DN is complex and still needs to be fully understood, lipid metabolism disorder is found to play a role in it. Previously, we found Yishen Huashi (YSHS) granule could inhibit diabetic damage and reduce level of microalbuminuria (mALB) in DN animals. . …
Although etiology for DN is complex and still needs to be fully understood, lipid metabolism disorder is found to play a role in it. Previou …
Zuogui-Jiangtang-Yishen decoction prevents diabetic kidney disease: Intervene pyroptosis induced by trimethylamine n-oxide through the mROS-NLRP3 axis.
Yi ZY, Peng YJ, Hui BP, Liu Z, Lin QX, Zhao D, Wang Y, Liu X, Xie J, Zhang SH, Huang JH, Yu R. Yi ZY, et al. Phytomedicine. 2023 Jun;114:154775. doi: 10.1016/j.phymed.2023.154775. Epub 2023 Mar 18. Phytomedicine. 2023. PMID: 36990008
Here, the associations between TMAO-induced pyroptosis and pathogenesis of DKD were studied, and the potential mechanism of Zuogui-Jiangtang-Yishen (ZGJTYS) decoction to prevent DKD was further investigated. ...
Here, the associations between TMAO-induced pyroptosis and pathogenesis of DKD were studied, and the potential mechanism of Zuogui-Jiangtang …
Yishen Capsule Alleviated Symptoms of Diabetic Nephropathy via NOD-like Receptor Signaling Pathway.
Zhang Z, Hu Y, Liu W, Zhang X, Wang R, Li H, Sun D, Fang J. Zhang Z, et al. Diabetes Metab Syndr Obes. 2022 Jul 26;15:2183-2195. doi: 10.2147/DMSO.S368867. eCollection 2022. Diabetes Metab Syndr Obes. 2022. PMID: 35923253 Free PMC article.
PURPOSE: To explore the mechanism of Yishen capsule against diabetic nephropathy (DN) based on the analysis of transcriptomics. ...However, pathological phenotypes mentioned above were alleviated after Yisen capsule administration. This result indicates that Yishen …
PURPOSE: To explore the mechanism of Yishen capsule against diabetic nephropathy (DN) based on the analysis of transcriptomics. ...Ho …
Yishen-Qingli-Huoxue formula attenuates renal fibrosis by inhibiting indoxyl sulfate via AhR/snai1 signaling.
Chen C, Sun S, Zhao J, Wu Q, He W, Sun W. Chen C, et al. Phytomedicine. 2023 Jan;108:154546. doi: 10.1016/j.phymed.2022.154546. Epub 2022 Nov 11. Phytomedicine. 2023. PMID: 36410103
BACKGROUND: Chronic kidney disease (CKD) is challenging to reverse and its treatment options are limited. Yishen-Qingli-Huoxue Formula (YQHF) is an effective treatment Chinese formula for CKD, as verified by clinical randomized controlled trial. ...
BACKGROUND: Chronic kidney disease (CKD) is challenging to reverse and its treatment options are limited. Yishen-Qingli-Huoxue Formul …
Tongluo Yishen Decoction Ameliorates Renal Fibrosis via NLRP3-Mediated Pyroptosis In Vivo and In Vitro.
Jia Q, Zhang X, Hao G, Zhao Y, Lowe S, Han L, Qin J. Jia Q, et al. Front Pharmacol. 2022 Jul 6;13:936853. doi: 10.3389/fphar.2022.936853. eCollection 2022. Front Pharmacol. 2022. PMID: 35873572 Free PMC article.
Purpose: In this study, we investigated the mechanism of Tongluo Yishen (TLYS) decoction in more detail, from the perspective of pyroptosis in the unilateral ureteral ligation (UUO) model and the hypoxia-induced renal tubular epithelial (NRK-52E) cell. ...
Purpose: In this study, we investigated the mechanism of Tongluo Yishen (TLYS) decoction in more detail, from the perspective of pyro …
[Research on the intervention of Yishen Huoxue prescription to renal fibrosis through the signal regulation by microRNA-126 to VEGF-Notch].
Zhong J, Zhao N, Liu C, Hu J, Zhang W, Xiong C, Chen H, Gong C. Zhong J, et al. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2018 Oct;30(10):991-995. doi: 10.3760/cma.j.issn.2095-4352.2018.010.018. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2018. PMID: 30439324 Chinese.
OBJECTIVE: To explore the molecular mechanism of Yishen Huoxue prescription in delaying the development of renal fibrosis by regulating the microRNA-126/vascular endothelial growth factor-Notch (miR-126/VEGF-Notch) signaling pathway. ...There was no significant difference …
OBJECTIVE: To explore the molecular mechanism of Yishen Huoxue prescription in delaying the development of renal fibrosis by regulati …
Yishen Huashi Granules Ameliorated the Development of Diabetic Nephropathy by Reducing the Damage of Glomerular Filtration Barrier.
Zhao T, Li M, Xiang Q, Lie B, Chen D, Wang W, Li X, Xu T, Zhang X, Li Y, Dong R, Du X, Wang Y, Yang J, He B, Zhu Q, Duan T, Li Z, Xu Y. Zhao T, et al. Front Pharmacol. 2022 Jul 22;13:872940. doi: 10.3389/fphar.2022.872940. eCollection 2022. Front Pharmacol. 2022. PMID: 35935814 Free PMC article.
Recent evidence has shown definite effects of Chinese medicine on DN. Yishen Huashi (YSHS) granule is a traditional Chinese Medicine prescription that has been used in the clinic to treat DN, but its mechanism is not understood. ...
Recent evidence has shown definite effects of Chinese medicine on DN. Yishen Huashi (YSHS) granule is a traditional Chinese Medicine …
[Effects of Yishen Tongluo Prescription on the PI3K-Akt-MTOR pathway and the protein and mRNA expressions of CatSper-1 and HSPA2 in the testis tissue of oligoasthenospermia rats].
Sun ZX, Qiu Q, He X, Zhang F, Zhao PP. Sun ZX, et al. Zhonghua Nan Ke Xue. 2022 May;28(5):437-444. Zhonghua Nan Ke Xue. 2022. PMID: 37477484 Chinese.
OBJECTIVE: To study the effect of Yishen Tongluo Prescription (YTP) on the testis tissue of the male rats with oligoasthenospermia (OAS) and its action mechanism based on the PI3K-AKT-mTOR pathway. ...Statistically significant differences were not observed in the mRNA expr …
OBJECTIVE: To study the effect of Yishen Tongluo Prescription (YTP) on the testis tissue of the male rats with oligoasthenospermia (O …
Effective-components combination alleviates PM2.5-induced inflammation by evoking macrophage autophagy in COPD.
Wang J, He W, Yue H, Zhao P, Li J. Wang J, et al. J Ethnopharmacol. 2024 Mar 1;321:117537. doi: 10.1016/j.jep.2023.117537. Epub 2023 Dec 2. J Ethnopharmacol. 2024. PMID: 38043756 Free article.
ETHNOPHARMACOLOGICAL RELEVANCE: Bufei Yishen formula (BYF) is clinically used to treat chronic obstructive pulmonary disease (COPD). ...
ETHNOPHARMACOLOGICAL RELEVANCE: Bufei Yishen formula (BYF) is clinically used to treat chronic obstructive pulmonary disease (COPD). …
Effective Component Compatibility of Bufei Yishen Formula III Which Regulates the Mucus Hypersecretion of COPD Rats via the miR-146a-5p/EGFR/MEK/ERK Pathway.
Ma J, Liu X, Wei Y, Lu R, Xu K, Tian Y, Li J. Ma J, et al. Evid Based Complement Alternat Med. 2022 Dec 28;2022:9423435. doi: 10.1155/2022/9423435. eCollection 2022. Evid Based Complement Alternat Med. 2022. PMID: 36619199 Free PMC article.
BACKGROUND: The effective-component compatibility of Bufei Yishen formula III (ECC-BYF III) with 5 ingredients (ginsenoside Rh1, astragaloside, icariin, nobiletin, and paeonol) has been shown to protect against chronic obstructive pulmonary disease (COPD). ...
BACKGROUND: The effective-component compatibility of Bufei Yishen formula III (ECC-BYF III) with 5 ingredients (ginsenoside Rh1, astr …
59 results